← All organizations
Highest phase reached
Phase 2
First clinical trial
Jun 3, 2024Last known activity
Dec 15, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 8 trials)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Recent trials (13)
- NCT07239739Lead sponsorN/ADec 15, 2025
- NCT07239739Sponsor investigatorN/ADec 15, 2025
- NCT07247630Lead sponsorEarly Phase 1Nov 15, 2025
- NCT07252258Sponsor investigatorN/AJul 15, 2025
- NCT07233564Lead sponsorN/AJul 15, 2025
- NCT07233564Sponsor investigatorN/AJul 15, 2025
- NCT07252258Lead sponsorN/AJul 15, 2025
- NCT06759454Sponsor investigatorN/AJun 30, 2025
- NCT06759454Lead sponsorN/AJun 30, 2025
- NCT06949904Lead sponsorPhase 1/Phase 2May 31, 2025
- NCT06949904Sponsor investigatorPhase 1/Phase 2May 31, 2025
- NCT06659406CollaboratorN/AJan 1, 2025
- NCT07123792Sponsor investigatorN/AJun 3, 2024
Details
- Last known activity
- Dec 15, 2025